同源康医药-B(02410)申请H股全流通

智通财经
Sep 13, 2024

智通财经APP讯,同源康医药-B(02410)发布公告,于2024年9月13日,该公司已就将公司1.74亿股非上市股股份(非上市股份)转换为H股(H股)以及该等股份于联交所上市(H股全流通)向中国证监会提交申请(该申请)。在取得所有相关监管机构(包括但不限于中国证监会及联交所)的备案及/或批准及符合所有适用法律、法规及规则后,该等非上市股份将被转换为H股及合资格在联交所主板上市买卖

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10